What Is Epithalon? Research Background on the Synthetic Pineal Tetrapeptide
Epithalon (also written Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It was developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology as a simplified analog of Epithalamin – a polypeptide complex extracted from bovine pineal gland tissue. Over the past three decades, Epithalon has become a prominent subject of preclinical research in gerontology, with studies examining its effects on telomere biology, telomerase activity, circadian gene expression, and neuroendocrine regulation.
This post summarizes published preclinical findings related to Epithalon’s molecular mechanisms. All referenced studies are conducted in cell culture systems or animal models. Epithalon is sold by Core Research Peptides exclusively for laboratory and preclinical research use.
Mechanism of Action: Telomerase Activation and hTERT Expression
The most studied mechanistic pathway attributed to Epithalon in preclinical models involves upregulation of telomerase reverse transcriptase (hTERT) – the catalytic subunit of the telomerase enzyme complex responsible for extending telomere repeat sequences at the ends of linear chromosomes.
A landmark cell biology study by Khavinson, Bondarev, and Butyugov (2003), published in Bulletin of Experimental Biology and Medicine (PMID: 12937682; DOI: 10.1023/a:1025493705728), reported that addition of Epithalon to telomerase-negative human fetal fibroblast cultures induced expression of the telomerase catalytic subunit, enzymatic activity, and measurable telomere elongation – approximately 33.3% on average compared to untreated controls. The authors proposed that the peptide may facilitate reactivation of the hTERT gene in somatic cell populations in which telomerase activity had been silenced.
A 2025 independent replication effort by Al-Dulaimi, Thomas, Matta, and Roberts, published in Biogerontology (PMID: 40908429; DOI: 10.1007/s10522-025-10315-x), examined multiple human cell lines and reported that Epithalon increased telomere length via two distinct mechanisms depending on cell type: telomerase upregulation in telomerase-competent lines and activation of Alternative Lengthening of Telomeres (ALT) pathways in telomerase-negative lines. The authors noted that these findings support biological plausibility of hTERT-independent mechanisms and suggest the peptide’s effects may operate across diverse cellular contexts.
Epigenetic and Neurogenesis-Related Findings
Beyond telomere biology, Epithalon has been studied for putative epigenetic activity. A 2020 paper by Khavinson, Diomede, Mironova, Linkova, and colleagues, published in Molecules (DOI: 10.3390/molecules25030609), examined AEDG peptide effects on neural stem/progenitor cells and reported stimulation of gene expression profiles associated with neurogenesis – including increases in SOX2, PCNA, and vimentin protein synthesis. The authors proposed that Epithalon may modulate chromatin accessibility or transcription factor binding as a possible epigenetic mechanism, though this remains under investigation and has not been confirmed in vivo.
Circadian Rhythm Gene Expression and Pineal Gland Research
Research from Ivko, Linkova, and colleagues (2021), published in Advances in Gerontology (DOI: 10.1134/S2079057021010380), explored how AEDG peptide affects expression of core circadian rhythm genes (CLOCK, BMAL1, PER1, CRY1) in human pineal gland cell cultures subjected to accelerated aging conditions. Their findings indicated modulation of circadian gene networks at the transcriptional level, consistent with Epithalon’s proposed role as a pineal bioregulator. The pineal gland is the primary source of melatonin synthesis, and circadian timing of melatonin release is tightly regulated by these gene networks.
Separately, a 2025 comprehensive review in PMC (PMID: 40141333; PMC: PMC11943447) consolidated 25+ years of Epithalon research and characterized it as exhibiting “significant geroprotective and neuroendocrine effects” across in vitro, in vivo, and in silico study designs. The authors noted that while the body of evidence is substantial for a preclinical research compound, human randomized controlled trials remain limited.
Frequently Asked Questions: Epithalon Research
What is the molecular structure of Epithalon?
Epithalon is a synthetic tetrapeptide composed of four amino acids in the sequence Ala-Glu-Asp-Gly (AEDG). It was synthesized as a minimal bioactive analog of the natural pineal extract Epithalamin, with a molecular weight of approximately 390 Da.
What does Epithalon do to telomerase in preclinical cell studies?
In telomerase-negative human fibroblast cultures, Khavinson et al. (2003) reported that Epithalon induced expression of the hTERT catalytic subunit and measurable enzymatic telomerase activity, resulting in average telomere elongation of ~33.3% compared to controls. A 2025 study (Al-Dulaimi et al.) replicated telomere extension across multiple human cell lines, identifying both telomerase-dependent and ALT-pathway mechanisms.
Is Epithalon related to the pineal gland?
Yes. Epithalon was derived from Epithalamin, a polypeptide extract of bovine pineal tissue. Preclinical research has examined its influence on circadian gene expression in pineal gland cell cultures and on melatonin secretion patterns in aged animal models, consistent with its classification as a “pineal peptide bioregulator” in the Russian gerontology literature.
What research models have been used to study Epithalon?
Published studies have used human fetal fibroblast cell cultures, various cancer and normal human cell lines, rat and mouse in vivo models, primate models (rhesus monkeys), and in silico computational docking approaches. All findings pertain to preclinical or non-clinical contexts.
Where can researchers source Epithalon for laboratory use?
Core Research Peptides supplies Epithalon as a research-grade compound with published COA (Certificate of Analysis) and verified purity data for use in preclinical laboratory settings. All products are sold strictly for research use only.
This content is for informational and educational purposes only. All products sold by Core Research Peptides are for research use only and not for human consumption. The findings cited above are derived from preclinical studies (cell cultures and animal models) and have not been evaluated by the FDA. No claims are made regarding therapeutic efficacy, safety in humans, or suitability for any clinical application.
In stock now
Epithalon 10mg, in stock in the United States
Core Research Peptides stocks Epithalon 10mg at $52 a vial with published bundle pricing at two, three and five units. Orders placed before 4PM ET dispatch the same day, seven days a week.
Read the Epithalon buying guideView Epithalon 10mgFree research guide for this compound at coreresearchpeptides.com/guides.
